We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTHI icon
1926
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.43B
$12K ﹤0.01%
600
– –
FTQI icon
1927
First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF
FTQI
$930M
$12K ﹤0.01%
600
– –
GGME icon
1928
Invesco Next Gen Media and Gaming ETF
GGME
$46.3M
$12K ﹤0.01%
+476
New +$12.1K
GSBD icon
1929
Goldman Sachs BDC
GSBD
$1.1B
$12K ﹤0.01%
+561
New +$11.7K
HBIO icon
1930
Harvard Bioscience
HBIO
$29.2M
$12K ﹤0.01%
452
-438
-49% -$12.2K
HEFA icon
1931
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.71B
$12K ﹤0.01%
+500
New +$12.2K
HQH
1932
abrdn Healthcare Investors
HQH
$1.32B
$12K ﹤0.01%
+499
New +$12.5K
HYG icon
1933
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$12K ﹤0.01%
143
-13,644
-99% -$1.17M
ITRI icon
1934
Itron
ITRI
$4.54B
$12K ﹤0.01%
210
-2,880
-93% -$138K
OPLN
1935
Openlane
OPLN
$4.54B
$12K ﹤0.01%
708
+425
+150% +$6.78K
MRTN icon
1936
Marten Transport
MRTN
$1.22B
$12K ﹤0.01%
1,393
+793
+132% +$6.81K
NBIX icon
1937
Neurocrine Biosciences
NBIX
$16.6B
$12K ﹤0.01%
+241
New +$12K
NCV
1938
Virtus Convertible & Income Fund
NCV
$390M
$12K ﹤0.01%
+450
New +$11.9K
NOM
1939
DELISTED
Nuveen Missouri Quality Municipal Income Fund
NOM
$12K ﹤0.01%
774
– –
NTB icon
1940
Bank of N.T. Butterfield & Son
NTB
$2.45B
$12K ﹤0.01%
+490
New +$11.9K
NWFL icon
1941
Norwood Financial Corp
NWFL
$368M
$12K ﹤0.01%
600
-117
-16% -$2.23K
PDFS icon
1942
PDF Solutions
PDFS
$2.07B
$12K ﹤0.01%
646
-1,035
-62% -$16.9K
PNRG icon
1943
PrimeEnergy Resources
PNRG
$298M
$12K ﹤0.01%
200
+16
+9% +$931
QMCO icon
1944
Quantum Corp
QMCO
$474M
$12K ﹤0.01%
105
-21
-17% -$2.05K
RARE icon
1945
Ultragenyx Pharmaceutical
RARE
$2.55B
$12K ﹤0.01%
165
-104
-39% -$6.64K
RCKY icon
1946
Rocky Brands
RCKY
$369M
$12K ﹤0.01%
1,105
-1,253
-53% -$13.7K
RFG icon
1947
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$358M
$12K ﹤0.01%
+475
New +$12K
SPXC icon
1948
SPX Corp
SPXC
$10.8B
$12K ﹤0.01%
580
-312
-35% -$5.53K
TEF
1949
DELISTED
Telefonica
TEF
$12K ﹤0.01%
1,545
-128
-8% -$991
TNDM icon
1950
Tandem Diabetes Care
TNDM
$1.56B
$12K ﹤0.01%
156
+69
+79% +$5.03K
76 77
78
79 80

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.